EVENTIDE ASSET MANAGEMENT, LLC

Holdings History for Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Symbol: ZNTL on Nasdaq
Investment type: Equity / Common Stock,$0.001 par value per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Eventide Asset Management, LLC ownership in Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL)

14 May 2025 - Eventide Asset Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL). This represents 0% ownership of the company. In their previous filing dated 14 Feb 2025, EVENTIDE ASSET MANAGEMENT, LLC had reported owning 4,475,054 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Eventide Asset Management, LLC	0%	-105%	$0	0	-4,475,054	-100%	$1.43	13G/A	31 Mar 2025	14 May 2025, 15:51
Eventide Asset Management, LLC	0%	-105%	$0	0	-4,475,054	-100%	$1.43	13G/A	31 Mar 2025	13 May 2025, 17:30
Eventide Asset Management, LLC	6.3%		$6,399,327	4,475,054			$1.43	13G/A	31 Dec 2024	14 Feb 2025, 12:13

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025		-0.25%	$0	0	-4,475,054	-100%	$2.55	Q1 2025
31 Dec 2024	0.25%	-0.22%	$13,558,372	4,475,054	-4,072,842	-48%	$3.03	Q4 2024
30 Sep 2024	0.54%	0%	$31,456,257	8,547,896	0		$3.68	Q3 2024
30 Jun 2024	0.6%	-0.19%	$34,960,895	8,547,896	-3,026,925	-26%	$4.09	Q2 2024
31 Mar 2024	2.9%	+0%	$182,419,179	11,574,821	+14,846	+0.13%	$15.76	Q1 2024
31 Dec 2023	2.9%	+0.93%	$175,133,621	11,559,975	+3,745,936	+48%	$15.15	Q4 2023
30 Sep 2023	2.8%	+0.34%	$156,749,622	7,814,039	+936,236	+14%	$20.06	Q3 2023
30 Jun 2023	3.3%	+1.7%	$194,022,823	6,877,803	+3,650,803	+113%	$28.21	Q2 2023
31 Mar 2023	1%	+0.34%	$55,504,400	3,227,000	+1,070,485	+50%	$17.20	Q1 2023
31 Dec 2022	0.86%	+0.12%	$43,432,212	2,156,515	+295,515	+16%	$20.14	Q4 2022
30 Sep 2022	0.79%	+0.37%	$40,309,000	1,861,000	+857,000	+85%	$21.66	Q3 2022
30 Jun 2022	0.6%	+0.15%	$28,212,000	1,004,000	+243,000	+32%	$28.10	Q2 2022
31 Mar 2022	0.55%	+0.17%	$35,113,000	761,000	+232,000	+44%	$46.14	Q1 2022
31 Dec 2021	0.57%	0%	$44,468,000	529,000	0		$84.06	Q4 2021
30 Sep 2021	0.47%	+0.1%	$35,253,000	529,000	+108,600	+26%	$66.64	Q3 2021
30 Jun 2021	0.3%	-0.29%	$22,365,000	420,400	-411,600	-49%	$53.20	Q2 2021
31 Mar 2021	0.54%	0%	$36,100,000	832,000	0		$43.39	Q1 2021
31 Dec 2020	0.67%	-0.06%	$43,214,000	832,000	-79,416	-8.7%	$51.94	Q4 2020
30 Sep 2020	0.58%	-0%	$28,822,000	911,416	-3,289	-0.36%	$31.62	Q3 2020
30 Jun 2020	0.95%	+0.95%	$42,496,000	914,705	+914,705	NEW	$46.46	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.